Table Of Content

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 30, No. 6, December 2003 (© 2003) Author Index for Volume 30 Amann, Anton, 23 Lalonde, Richard L., 168 Linden, Monique van der, 3 Beal, Stuart L., 387, 405 Ludden, Thomas M.. 54 Bjorkman, Sven, 285 Burggraaf, Jacobus, 3 McFadyen. Lynn, 315 Mentre. France, 417 Cohen. Adam F., 3 Miller, Raymond. 168, 315 Comets. Emmanuelle. 257 Moerland, Matthijs. 3 Moriwaki, Toshiya, 119 D'Argenio, David Z., 185 Mu. Song, 54 Duffull. Stephen, 145 Nigrovic, Vladimir, 23 Egorin, Merrill J., 185 Noordzij, Marina, 3 Eiseman. Julie L., 185 Eleveld, Douglas J., 105 0sterberg, Ole, 221 Endrenyi, Laszlo, 363 Erichsen, Lars. 221 Plum. Anne, 221 Poulsen. Heinrik. 221 Frame, Bill, 168. 315 Proost, Johannes H., 105 Fumoleau. Pierre, 257 Retout, Sylvie, 417 Green, Bruce, 145 Sale, Mark. 83 Haes, Ann De, 105 Schoemaker, Rik C.C., 3 Higashimori, Mitsuo, 309 Sheiner. Lewis B.. 387, 405 Hoff. Paulo, 257 Hu. Chuanpu, 83 Hutmacher, Matthew, 315 Tanigawara, Yusuke, 257 Thorsson, Lars. 239 Ikeda, Kazumasa, 257 Tothfalusi, Laszlo, 363 Ingwersen, Steen. H., 221 Verotta, Davide, 315 Kiillen. Anders, 239 Vicini, Paolo, 221 Kemme, Michiel J.B., 3 Kluft, Cornelis, 3 Wanders, Jantien, 257 Kowalski. Kenneth G., 315 Wierda, J. Mark K.H., 105 445 1567-567X 03 1200' ()445 0 xj 2003 Plenum Publishing Corporation 446 Author Index for Volume 30 Xu, Lu, 185 Yasui. Hiroyuki, 119 Yamamoto, Akira, 119 Zhang, Liping, 387, 405 Yamaoka, Kiyoshi, 309 Journal of Pharmacokinetics and Pharmacodynamics, Vol. 30, No. 6, December 2003 (© 2003) Subject Index for Volume 30 Acetylcholine, 23 Intrinsic clearance, 185 Adverse events, 315 Auto-regulation, 185 Lumping, 285 Bayesian estimation, 185 Missing data, 83 Bias of estimated metrics, 363 Mixed effects, 83 Bioavailability, 119 Mixed effects model, 168 Bioequivalence, 363 Mixture model, 168, 315 Budesonide, 239 Model evaluation, 168 Model misspecification, 315 Cephradine, 119 Model validation, 257 Clinical pharmacology, 363 Modeling, 105, 221, 387, 405 Cmax, 363 MULTl(FILT), 119 Count data, 168 Data analysis, 387, 405 Neuromuscular block, 23 Designs optimization, 417 Neuromuscular relaxants, 105 D-optimality, 145,417 Neuromuscular transmission simulation, 23 Drug disposition analysis, 239 Nondepolarizing muscule relaxants, 23 Nonlinear mixed effects modeling, 417 Empirical Bayes predictions, 315 Nonlinear mixed effects models, 315 enoxaprin, 145 Nonlinear models, 83 Enterohepatic circulation, 119 NONMEM, 315 Ethnic differences, 257 Nonparametric model Fisher information matrix, 417 Onco-protein, 185 Fluticasone, 239 Opioids, 285 Forcing function, 387, 405 Oral anticancer drug, 257 Geldanamycin, 185 Patient compliance, 54 Glucocorticosteroids, 239 Pharmacodynamic, 221, 337, 387 Pharmacokinetic, 221 Heat shock protein, 185 Pharmacokinetic simulations, 363 Hierarchical Bayesian models, 54 Pharmacokinetics, 3, 105, 119, 145, 285, 337, Human, 3 387, 405, 417 Physiologically-based pharmacokinetics, 185 Indocyanine green, 3 Poisson distribution, 168 Insulin apart, 221 Population analysis, 145 447 1567-567X/03; 1200-0447/0 ® 2003 Plenum Publishing Corporation 448 Subject Index for Volume 30 Population modeling. 83 Tissue distribution, 285 Population pharmacokinetics, 54, 257, 363 Tissue plasminogen activator, 3 Predictive performance, 168 T’max, 363 P-S difference, 119 Train-of-four simulation, 105 Twitch simulation, 23 Recirculatory model, 119 Volterra series, 337 Simplex algorithm. 417 Simulation, 23 Whole body physiologically based model, Steady-state pharmacokinetics, 363 285 I